Assessing the impact of a typhoid conjugate vaccine introduced in an urban community
Phase 4
- Registration Number
- CTRI/2022/03/041314
- Lead Sponsor
- Christian Medical College Vellore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Provide written informed consent
Residents of study area
Exclusion Criteria
Has received a typhoid vaccine in the previous three years
Is known to have an allergy to any vaccine component
Pregnancy or planning pregnancy around vaccination
Receipt of any other vaccine in the past 30 days (temporary exclusion)
Febrile illness in the 24 hours before vaccination (temporary exclusion)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cumulative number of Blood culture confirmed typhoid feverTimepoint: 24 months after randomization
- Secondary Outcome Measures
Name Time Method Cumulative number of febrile hospitalizationsTimepoint: 24 months after randomization;Number of solicited adverse eventsTimepoint: 7 days after vaccination